Opus Genetics, Inc. business relationships

Companies named in Opus Genetics, Inc.’s 10-K filed 2026-03-12, and public companies whose annual reports name Opus Genetics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.6 / 10
AI naming: <1 / 100
Agent readiness: 30 / 100
AI adoption: 0 / 100

Named in Opus Genetics, Inc.’s annual report 4

Viatris Inc (VTRS)Licensee6.6
“potential milestone and royalty payments from the agreements with Viatris or from other license agreements entered into the future; however, the attainment of milestones or level of sales required to earn significant royalty payments is” SEC filing
Viatris Inc (VTRS)Licensor6.6
“Viatris License Agreement” SEC filing
Viatris Inc (VTRS)Partner6.6
“We already have a collaboration with Viatris for the development and” SEC filing
Processa Pharmaceuticals, Inc. (PCSA)Licensor4.7
“Company entered into a license agreement (the "Processa License Agreement") with Processa Pharmaceuticals, Inc. ("Processa"), pursuant to which the Company agreed to grant Processa an exclusive license to develop, manufacture and commercialize” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.